-
Phone :
+852 64053293
+852 66899358
-
-
Wan Chai District, Hong Kong, China
The correlation between declining NAD levels and the aging process has opened exciting new avenues for therapeutic intervention. Research is focused on strategies to boost NAD bioavailability, primarily through the use of NAD precursors like Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN). By enhancing NAD levels, the goal is to support fundamental cellular processes, promote healthy aging, and potentially address conditions linked to mitochondrial dysfunction.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
Please leave a message below, and we will get back to you at the earliest convenience.
We have breakthrough capabilities in high-activity peptide purification, long-acting sustained-release formulations, and other key technologies, ensuring ultimate quality from raw materials to final products.